John Libbey Eurotext

European Journal of Dermatology

Primary cutaneous cryptococcosis successfully managed by surgical debridement and liposomal amphotericin B/flucytosine therapy Volume 27, issue 1, January-February 2017

Figures

  • Figure 1
Authors
1 Department of Dermatology,
Graduate School of Medical Sciences,
Kyushu University, 3-1-1, Maidashi,
Higashi-ku, Fukuoka,
812-8582, Japan,
2 Clinical, Research Center for Yusho,
Dioxin, Kyushu University, 3-1-1,
Maidashi, Higashi-ku, Fukuoka,
812-8582, Japan,
3 Department of Dermatology,
Kitakyushu Municipal Medical Center,
2-1-1, Bashaku, Kokurakita-ku, Kokura,
802-0077, Japan

Primary cutaneous cryptococcosis (PCC) is caused by inoculation of Cryptococcus into the skin, which is the only organ or tissue affected [1]. Because PCC is rare, the effectiveness of surgical debridement in combination with antifungal drug therapy in PCC remains unclear. Herein, we report a patient with PCC who was successfully managed with surgical debridement in combination with liposomal amphotericin B and flucytosine therapy.A 70-year-old housewife with a past medical history of scleroderma [...]